150 related articles for article (PubMed ID: 31537095)
21. Effect of various doses of intravenous polyclonal IgG on in vivo levels of 12 pneumococcal antibodies in patients with chronic lymphocytic leukaemia and multiple myeloma.
Sklenar I; Schiffman G; Jønsson V; Verhoef G; Birgens H; Boogaerts M; Ferrant A; Christensen BE; Hasle H; Drivsholm A
Oncology; 1993; 50(6):466-77. PubMed ID: 8233289
[TBL] [Abstract][Full Text] [Related]
22. Clinical significance of serum immunoglobulin G subclass deficiency in patients with chronic lymphocytic leukemia.
Svensson T; Höglund M; Cherif H
Scand J Infect Dis; 2013 Jul; 45(7):537-42. PubMed ID: 23427875
[TBL] [Abstract][Full Text] [Related]
23. Intravenous versus subcutaneous immunoglobulin replacement in secondary hypogammaglobulinemia.
Spadaro G; Pecoraro A; De Renzo A; Della Pepa R; Genovese A
Clin Immunol; 2016 May; 166-167():103-4. PubMed ID: 27063866
[TBL] [Abstract][Full Text] [Related]
24. Disease activity and pretreatment, rather than hypogammaglobulinaemia, are major risk factors for infectious complications in patients with chronic lymphocytic leukaemia.
Hensel M; Kornacker M; Yammeni S; Egerer G; Ho AD
Br J Haematol; 2003 Aug; 122(4):600-6. PubMed ID: 12899715
[TBL] [Abstract][Full Text] [Related]
25. Should treatment of hypogammaglobulinemia with immunoglobulin replacement therapy (IgRT) become standard of care in patients with chronic lymphocytic leukemia?
Noto A; Cassin R; Mattiello V; Bortolotti M; Reda G; Barcellini W
Front Immunol; 2023; 14():1062376. PubMed ID: 37122737
[TBL] [Abstract][Full Text] [Related]
26. Nonspecific immunoglobulin replacement in lung transplantation recipients with hypogammaglobulinemia: a cohort study taking into account propensity score and immortal time bias.
Claustre J; Quétant S; Camara B; France M; Schummer G; Bedouch P; Pavese P; Saint Raymond C; Bardy B; Masson D; Roth H; Pison C;
Transplantation; 2015 Feb; 99(2):444-50. PubMed ID: 25099705
[TBL] [Abstract][Full Text] [Related]
27. Preterm infants with low immunoglobulin G levels have increased risk of neonatal sepsis but do not benefit from prophylactic immunoglobulin G.
Sandberg K; Fasth A; Berger A; Eibl M; Isacson K; Lischka A; Pollak A; Tessin I; Thiringer K
J Pediatr; 2000 Nov; 137(5):623-8. PubMed ID: 11060526
[TBL] [Abstract][Full Text] [Related]
28. Early and prolonged intravenous immunoglobulin replacement therapy in childhood agammaglobulinemia: a retrospective survey of 31 patients.
Quartier P; Debré M; De Blic J; de Sauverzac R; Sayegh N; Jabado N; Haddad E; Blanche S; Casanova JL; Smith CI; Le Deist F; de Saint Basile G; Fischer A
J Pediatr; 1999 May; 134(5):589-96. PubMed ID: 10228295
[TBL] [Abstract][Full Text] [Related]
29. [Intravenous and subcutaneous immunoglobulin therapy].
Thon V
Epidemiol Mikrobiol Imunol; 2013 Jul; 62(2):64-73. PubMed ID: 23964967
[TBL] [Abstract][Full Text] [Related]
30. [Immunoglobulin replacement therapy contribution in agammaglobulinemia: 10 case reports].
Ksouri H; Mellouli F; Barbouch R; Ben Hassen A; Béjaoui M
Arch Pediatr; 2006 Jul; 13(7):1034-9. PubMed ID: 16713207
[TBL] [Abstract][Full Text] [Related]
31. Treatment of hypogammaglobulinaemia with intravenous immunoglobulin, 1973-93.
Skull S; Kemp A
Arch Dis Child; 1996 Jun; 74(6):527-30. PubMed ID: 8758130
[TBL] [Abstract][Full Text] [Related]
32. The efficacy of immunoglobulin replacement therapy in the long-term follow-up of the B-cell deficiencies (XLA, HIM, CVID).
Bayrakci B; Ersoy F; Sanal O; Kiliç S; Metin A; Tezcan I
Turk J Pediatr; 2005; 47(3):239-46. PubMed ID: 16250308
[TBL] [Abstract][Full Text] [Related]
33. Risk factors for infection and immunoglobulin replacement therapy in adult nephrotic syndrome.
Ogi M; Yokoyama H; Tomosugi N; Hisada Y; Ohta S; Takaeda M; Wada T; Naito T; Ikeda K; Goshima S
Am J Kidney Dis; 1994 Sep; 24(3):427-36. PubMed ID: 8079968
[TBL] [Abstract][Full Text] [Related]
34. Hypogammaglobulinemia after heart transplantation: use of intravenous immunoglobulin replacement therapy in relapsing CMV disease.
Sarmiento E; Fernàndez-Yáñez J; Muñoz P; Palomo J; Rodríguez-Molina JJ; Bermejo J; Catalan P; Bouza E; Fernández-Cruz E; Carbone J
Int Immunopharmacol; 2005 Jan; 5(1):97-101. PubMed ID: 15589466
[TBL] [Abstract][Full Text] [Related]
35. The comparison of the efficacy and safety of intravenous versus subcutaneous immunoglobulin replacement therapy.
Chapel HM; Spickett GP; Ericson D; Engl W; Eibl MM; Bjorkander J
J Clin Immunol; 2000 Mar; 20(2):94-100. PubMed ID: 10821460
[TBL] [Abstract][Full Text] [Related]
36. Immunoglobulin replacement in chronic lymphocytic leukaemia.
Bunch C
Nouv Rev Fr Hematol (1978); 1988; 30(5-6):419-22. PubMed ID: 3065737
[TBL] [Abstract][Full Text] [Related]
37. Secondary antibody deficiencies.
Dhalla F; Misbah SA
Curr Opin Allergy Clin Immunol; 2015 Dec; 15(6):505-13. PubMed ID: 26406183
[TBL] [Abstract][Full Text] [Related]
38. Immunoglobulin prophylaxis in chronic lymphocytic leukemia and multiple myeloma: systematic review and meta-analysis.
Raanani P; Gafter-Gvili A; Paul M; Ben-Bassat I; Leibovici L; Shpilberg O
Leuk Lymphoma; 2009 May; 50(5):764-72. PubMed ID: 19330654
[TBL] [Abstract][Full Text] [Related]
39. Humoral immune failure defined by immunoglobulin class and immunoglobulin G subclass deficiency is associated with shorter treatment-free and overall survival in Chronic Lymphocytic Leukaemia.
Crassini KR; Zhang E; Balendran S; Freeman JA; Best OG; Forsyth CJ; Mackinlay NJ; Han P; Stevenson WS; Mulligan SP
Br J Haematol; 2018 Apr; 181(1):97-101. PubMed ID: 29468645
[TBL] [Abstract][Full Text] [Related]
40. Immunoglobulin dosage and switch from intravenous to subcutaneous immunoglobulin replacement therapy in patients with primary hypogammaglobulinemia: decreasing dosage does not alter serum IgG levels.
Thépot S; Malphettes M; Gardeur A; Galicier L; Asli B; Karlin L; Gérard L; Laumont R; Doize ML; Arnulf B; Fieschi C; Bengoufa D; Oksenhendler E
J Clin Immunol; 2010 Jul; 30(4):602-6. PubMed ID: 20393788
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
